Medical Innovation Exchange

With new data in hand, Amgen plans to take heart drug into phase 3 to challenge Novartis

https://www.fiercebiotech.com/biotech/new-data-hand-amgen-plans-take-phase-3-dive-heart-drug-challenging-novartis-competitor

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!